Healthline23d
Dosage for Mounjaro: What You Need to Know
It’s a type of drug called a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide ... highlights the basics of Mounjaro’s dosage. The strengths in this chart are ...
Daily2d
Glucagon Sensitivity Similar in Individuals With and Without Type 1 Diabetes: Study Finds
"Overall, metabolic responses to glucagon stimulation in individuals with type 1 diabetes are comparable to those in healthy ...
Hosted on MSN2d
Novo Nordisk reports topline data from Phase Ib/IIa trial of weight loss therapy
Novo Nordisk has reported topline outcomes from a Phase Ib/IIa trial of amycretin designed for treating obese or overweight ...
Outsourcing-pharma1d
Novo Nordisk’s next-generation obesity drug shows promise in early clinical trials
Novo Nordisk’s amycretin shows 22% weight loss over 36 weeks, potentially surpassing Eli Lilly’s Zepbound. Further trials are ...
PMLiVE6h
Novo Nordisk’s Ozempic granted FDA approval in chronic kidney disease
Novo Nordisk’s Ozempic (semaglutide) has been approved by the US Food and Drug Administration (FDA) to reduce the risk of ...
Outsourcing-pharma8d
Novo Nordisk reports positive results for high-dose Wegovy formulation
Results from Novo Nordisk's STEP UP trial show that a high-dose formulation of Wegovy can significantly increase the weight ...